Alpha Growth plc
("Alpha, or the "Company")
Notice of Annual General Meeting ("AGM")
Alpha Growth plc (LSE: ALGW), the financial services specialist in the growing Senior Life Settlement ("SLS") asset class announces that its Annual Report and Accounts for the year ended 31 August 2018 and Notice of AGM have been posted to shareholders.
The Company will be holding the AGM at 8am on 4th March 2019, at the offices of PKF Littlejohn LLP at 1 Westferry Circus, Canary Wharf, London E14 4HD, UK.
Copies of the Annual Report and Account and the Notice of AGM are available on the Company's website at www.algwplc.com.
The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.
For more information, please visit www.algwplc.com or contact the following:
Alpha Growth plc |
+44 (0) 20 3959 8600 |
Gobind Sahney, Executive Chairman |
|
|
|
Vox Markets (Digital IR) |
+44 (0) 203 865 0130 |
Abraham Darwyne |
|
|
|
Novum Securities Limited (Corporate Broker) |
+44 (0) 207 399 9400 |
Colin Rowbury |
About Alpha Growth plc
Specialist in Longevity Assets
Alpha Growth plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets. Building on its well-established network, Alpha Growth has a unique position in the longevity asset services and investment business, as a listed entity with global reach. The Company's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide wholistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.